Degenerative Disc Disease, Events and Treatment

Degenerative Disc Disease

Events

Treatment

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

OrthoSpineNews

MAY 13, 2025

No serious adverse events (SAEs) were reported, and there was no dose (40X10 6 cells) limiting toxicity at 26-104 weeks. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Clinic Treatment

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

OrthoSpineNews

MARCH 3, 2025

This event marks the beginning of SST’s U.S.-based based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD).

Degenerative Disc Disease

Degenerative Disc Disease Patients Spine Clinic

Join 5,000+

Insiders

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

BioRestorative Announces Share Repurchase Program

OrthoSpineNews

JUNE 17, 2025

We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc. We have also obtained U.S.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Treatment Clinic

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

OrthoSpineNews

JUNE 23, 2025

Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD).

Degenerative Disc Disease

Degenerative Disc Disease Spine Vertebrae Treatment

Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine

OrthoSpineNews

JULY 8, 2025

million of the aggregate purchase price was paid to Xtant as a non-refundable cash deposit, except in the event Companion Spine terminates the Coflex/CoFix agreement due to certain breaches by Xtant under the agreement. million cash deposits may be paid to Xtant by Companion Spine in the event it requires extra time to obtain financing.

Spine

Spine Degenerative Disc Disease Musculoskeletal Treatment

Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval

OrthoSpineNews

JULY 8, 2025

The first post-approval procedure on an adult patient with degenerative disc disease (DDD) was performed by neurosurgeon Sharad Rajpal, M.D., “My goal is to bring my patients the most innovative and appropriate treatments specific to their needs, so they can regain their quality of life as soon as possible.

Degenerative Disc Disease

Degenerative Disc Disease Patients Spine Vertebrae

The 18 Most Popular Chiropractic Tools and Equipment

ChiroTouch

JULY 19, 2024

Today’s chiropractors use an impressive array of chiropractic tools and equipment designed to enhance diagnosis, treatment, and prevention of a wide range of conditions. The cushioned handle and trigger provide comfort and protection for the practitioner’s hand, ensuring ease of use during treatments. Stationary tables.

X-ray

X-ray Soft Tissue Injuries Vertebrae Chiropractic

Enhancing Well-Being Through Chiropractic Spinal Adjustments

Any Spine

SEPTEMBER 30, 2024

Clinical trials have shown the effectiveness of chiropractic spinal adjustments in reducing pain, including issues in the shoulder area, often providing a complementary option alongside other treatments like acupuncture. These practices aim to improve spinal health, which is crucial for overall well-being.

Spinal Adjustment

Spinal Adjustment Adjustment Chiropractic Neck Pain

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion

OrthoSpineNews

MARCH 10, 2025

The REFINE study, designed to bridge the gap between conservative treatments and more invasive surgical options, has successfully enrolled its full cohort of patients across multiple centers in the United States. CARLSBAD, Calif., We are incredibly proud to reach this milestone, said Trent Northcutt, President and CEO of Aurora Spine.

Degenerative Disc Disease

Degenerative Disc Disease Spine Musculoskeletal Clinic

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

OrthoSpineNews

JUNE 13, 2025

Excellent Safety Profile: No serious adverse events (SAEs) or dose-limiting toxicities reported between 26 and 104 weeks at the target dose (40 million cells). About the BRTX-100 Phase 2 Trial BRTX-100 is a novel, autologous cell-based therapy designed to treat patients suffering from painful lumbosacral disc degeneration.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Clinic Treatment

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

OrthoSpineNews

MAY 14, 2025

Disc/Spine Program In a February podium presentation at the Orthopaedic Research Society (ORS) Annual Meeting, BioRestoratives Vice President of Research and Development, Francisco Silva, presented 2652 week blinded data from the first 15 patients with chronic lumbar disc disease (cLDD) enrolled in the ongoing Phase 2 clinical trial of BRTX-100.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment

How a Powerful Chiropractic Newsletter Transforms Patient Relationships

MyChiroPractice

MAY 28, 2025

Each time your name appears in their inbox, it strengthens your connection and builds upon the trust established in your treatment room. Your newsletter demonstrates your commitment to patient education and overall wellness, not just symptom treatment. This demonstrates your commitment to the community beyond just business.

Patients

Patients Degenerative Disc Disease Chiropractic Adjustment

Chiropractic Pulse

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

Trending Sources

BioRestorative Announces Share Repurchase Program

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine

Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval

The 18 Most Popular Chiropractic Tools and Equipment

Enhancing Well-Being Through Chiropractic Spinal Adjustments

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

How a Powerful Chiropractic Newsletter Transforms Patient Relationships

Stay Connected